There is no evidence that antiplatelet agents reduce atherosclerotic risk in patients with HF.没有任何证据表明，抗血小板制剂降低心衰患者动脉粥样硬化的危险。
Evidence that particular chemokine pathways may cooperate to promote monocyte accumulation into inflamed tissues, particularly atherosclerotic arteries, is still lacking.有证据表明特殊趋化因子通路可能促进单核细胞在发炎的组织中聚集，但在动脉粥样硬化的动脉中缺乏显著证据。
